UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

miR-144 attenuates the host response to influenza virus by targeting the TRAF6-IRF7 signaling axis

PLoS pathogens, 2017-04, Vol.13 (4), p.e1006305-e1006305

2017

Link zum Volltext

Verfügbarkeit prüfen

Generation and Protective Ability of Influenza Virus–Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge

The Journal of infectious diseases, 2016-09, Vol.214 (6), p.945-952

2016

Link zum Volltext

Verfügbarkeit prüfen

SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans

Nature medicine, 2017-08, Vol.23 (8), p.975-983

2017

Link zum Volltext

Verfügbarkeit prüfen

Uncovering a macrophage transcriptional program by integrating evidence from motif scanning and expression dynamics

PLoS computational biology, 2008-03, Vol.4 (3), p.e1000021-e1000021

2008

Link zum Volltext

Verfügbarkeit prüfen

miR-451 regulates dendritic cell cytokine responses to influenza infection

The Journal of immunology (1950), 2012-12, Vol.189 (12), p.5965-5975

2012

Link zum Volltext

Verfügbarkeit prüfen

A Prognostic Model of Persistent Bacteremia and Mortality in Complicated Staphylococcus aureus Bloodstream Infection

Clinical infectious diseases, 2019-04, Vol.68 (9), p.1502-1511

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model

Antimicrobial agents and chemotherapy, 2017-11, Vol.61 (11)

2017

Link zum Volltext

Verfügbarkeit prüfen

Early plasma angiopoietin-2 is prognostic for ARDS and mortality among critically ill patients with sepsis

Critical care (London, England), 2023-06, Vol.27 (1), p.234-234, Article 234

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients

Antimicrobial agents and chemotherapy, 2017-02, Vol.61 (2)

2017

Link zum Volltext

Verfügbarkeit prüfen

Astegolimab or Efmarodocokin Alfa in Patients With Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial

Critical care medicine, 2023-01, Vol.51 (1), p.103

2023

Link zum Volltext

Verfügbarkeit prüfen

Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens

Nature reviews. Molecular cell biology, 2003-05, Vol.4 (5), p.385-396

2003

Link zum Volltext

Verfügbarkeit prüfen

Differential host response, rather than early viral replication efficiency, correlates with pathogenicity caused by influenza viruses

PloS one, 2013-09, Vol.8 (9), p.e74863-e74863

2013

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and pharmacodynamics of DSTA4637A: A novel THIOMAB™ antibody antibiotic conjugate against Staphylococcus aureus in mice

mAbs, 2016-11, Vol.8 (8), p.1612-1619

2016

Link zum Volltext

Verfügbarkeit prüfen

Interplay between Antibacterial Effectors: A Macrophage Antimicrobial Peptide Impairs Intracellular Salmonella Replication

Proceedings of the National Academy of Sciences - PNAS, 2004-02, Vol.101 (8), p.2422-2427

2004

Link zum Volltext

Verfügbarkeit prüfen

Surfactant protein D is a biomarker of influenza‐related pediatric lung injury

Pediatric pulmonology, 2022-02, Vol.57 (2), p.519-528

2022

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of severe acute respiratory syndrome coronavirus‐2 viral load and antibodies in patients hospitalized with COVID‐19

Clinical and translational science, 2023-06, Vol.16 (6), p.1049-1062

2023

Link zum Volltext

Verfügbarkeit prüfen

Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis

Cellular microbiology, 2008-02, Vol.10 (2), p.388-403

2008

Link zum Volltext

Verfügbarkeit prüfen

Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease

BMC pulmonary medicine, 2021-09, Vol.21 (1), p.301-301, Article 301

2021

Link zum Volltext

Verfügbarkeit prüfen

ATF3 regulates MCMV infection in mice by modulating IFN-γ expression in natural killer cells

Proceedings of the National Academy of Sciences - PNAS, 2008-02, Vol.105 (7), p.2544-2549

2008

Link zum Volltext

Verfügbarkeit prüfen

Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19

iScience, 2023-09, Vol.26 (9), p.107597-107597, Article 107597

2023

Link zum Volltext

Verfügbarkeit prüfen

Toll-Like Receptor 4 Contributes to Colitis Development but Not to Host Defense during Citrobacter rodentium Infection in Mice

Infection and Immunity, 2006-05, Vol.74 (5), p.2522-2536

2006

Link zum Volltext

Verfügbarkeit prüfen

Characterization of innate responses to influenza virus infection in a novel lung type I epithelial cell model

Journal of general virology, 2014-02, Vol.95 (Pt 2), p.350-362

2014

Link zum Volltext

Verfügbarkeit prüfen

A bronchial gene signature specific for severe COPD that is retained in the nose

ERJ open research, 2023-11, Vol.9 (6), p.354

2023

Link zum Volltext

Verfügbarkeit prüfen

A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm

mBio, 2011-03, Vol.2 (1), p.e00325-e00310

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(64)
Berichte
(1)

Sprache

Englisch
(65)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

miR-144 attenuates the host response to influenza virus by targeting the TRAF6-IRF7 signaling axis

Generation and Protective Ability of Influenza Virus–Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge

SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans

Uncovering a macrophage transcriptional program by integrating evidence from motif scanning and expression dynamics

Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial

miR-451 regulates dendritic cell cytokine responses to influenza infection

A Prognostic Model of Persistent Bacteremia and Mortality in Complicated Staphylococcus aureus Bloodstream Infection

Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model

Early plasma angiopoietin-2 is prognostic for ARDS and mortality among critically ill patients with sepsis

Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients

Astegolimab or Efmarodocokin Alfa in Patients With Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial

Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens

Differential host response, rather than early viral replication efficiency, correlates with pathogenicity caused by influenza viruses

Pharmacokinetics and pharmacodynamics of DSTA4637A: A novel THIOMAB™ antibody antibiotic conjugate against Staphylococcus aureus in mice

Interplay between Antibacterial Effectors: A Macrophage Antimicrobial Peptide Impairs Intracellular Salmonella Replication

Surfactant protein D is a biomarker of influenza‐related pediatric lung injury

Prognostic value of severe acute respiratory syndrome coronavirus‐2 viral load and antibodies in patients hospitalized with COVID‐19

Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis

Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease

ATF3 regulates MCMV infection in mice by modulating IFN-γ expression in natural killer cells

Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19

Toll-Like Receptor 4 Contributes to Colitis Development but Not to Host Defense during Citrobacter rodentium Infection in Mice

Characterization of innate responses to influenza virus infection in a novel lung type I epithelial cell model

A bronchial gene signature specific for severe COPD that is retained in the nose

A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm

Suchergebnisse filtern